| Pharmaceutical Information |
| Drug Name |
Procainamide hydrochloride |
| Drug ID |
BADD_D01843 |
| Description |
A derivative of procaine with less CNS action. |
| Indications and Usage |
For the treatment of life-threatening ventricular arrhythmias. |
| Marketing Status |
approved |
| ATC Code |
C01BA02 |
| DrugBank ID |
DB01035
|
| KEGG ID |
D00477
|
| MeSH ID |
D011342
|
| PubChem ID |
66068
|
| TTD Drug ID |
D0U5SI
|
| NDC Product Code |
76329-3399; 14789-900; 58747-7010; 51662-1630; 69575-4028; 14789-901; 66219-0005; 0409-1902; 49452-6031 |
| UNII |
SI4064O0LX
|
| Synonyms |
Procainamide | Procaine Amide | Amide, Procaine | Biocoryl | Novocainamide | Novocamid | Procainamide Hydrochloride | Hydrochloride, Procainamide | Procan | Procan SR | Procanbid | Pronestyl | Rhythmin | Apo-Procainamide | Procamide |
|
| Chemical Information |
| Molecular Formula |
C13H22ClN3O |
| CAS Registry Number |
614-39-1 |
| SMILES |
CCN(CC)CCNC(=O)C1=CC=C(C=C1)N.Cl |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
